The reluctance of people to receive safe and recommended available vaccines, known as ‘vaccine hesitancy’, was already a growing concern before the COVID-19 pandemic, there is a communication gap in vaccine information alongside misinformation, new methodologies are needed to monitor emerging vaccine concerns over time and place in order to better inform appropriate responses. Vaccine hesitancy at a local level is one important step toward addressing it, along with other needed interventions at the individual and community levels.

The reasons for COVID-19 vaccine acceptance and hesitancy remain complex. As new SARS-CoV-2 variants emerge, adding further complexity, and as new vaccines become available to the market, it will be important to maintain a delicate balance in communicating what is known and acknowledging the uncertainties that remain.

Vaccines are the most effective tools to protect individuals against vaccine-preventable diseases (VPDs) — including COVID-19. For people with chronic medical conditions, vaccines reduce the risk of further deterioration of health and death owing to VPDs. Vaccination protects vaccinated individuals and indirectly protects those who cannot be immunized or who do not respond robustly to vaccination, through the development of community immunity. The people and communities take up a challenge World Health Organization Immunization Agenda 2030, which emphasizes ‘leaving no one behind’ and ensuring immunization across the life course. The health-care and public health systems domain highlights the role of immunization programmes and health policies.

Source: CDC   https://www.cdc.gov/vaccines/covid-19/health-departments/addressing-vaccine-misinformation.html

Reference : https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/community.html